Fundraising Fox

Quit Genius

Founded 2017 · 178 employees on LinkedIn · 5 known investors

Pelago provides virtual-first substance use treatment for tobacco, alcohol, opioids, cannabis, and stimulants, combining digital tools, live counseling, and medication-assisted treatment for employers and organizations.

Digital HealthEnterprise SoftwareHealthtech

Investors · 5

AAF Management Ltd.Washington
Burda Principal InvestmentsMunich
AtomicoreportedLondon
Octopus VenturesreportedLondon · $130K – $1.3M
Y CombinatorreportedSan Francisco · $500K

Founder mafia

3 people who came through Quit Genius went on to found or lead other companies.

Seb WallaceInvestorFounded Triple PointDr Ashish Mandavia MDEMEA Commercial DirectorFounded Sohar HealthLucas GordonSenior Software EngineerFounded Sohar Health

In the news

Addiction treatment startup Quit Genius raises $64M - MedCity Newsmedcitynews.com · Jul 2021Quit Genius Raises $64M in Series B Funding - FinSMEsfinsmes.com · Jul 2021Quit Genius Raises $64M to Expand Access To #1 Digital Clinic for Substance Addictionsprnewswire.com · Jul 2021Quit Genius Bags $11m in Series A to Fight Addiction - Healthcare Weeklyhealthcareweekly.com · Mar 2020Quit Genius Scores $11 Million in Latest Funding Round - Behavioral Health Businessbhbusiness.com · Mar 2020Quit Genius raises $11M Series A to expand into opioid, alcohol addiction treatment | TechCrunchtechcrunch.com · Mar 2020Quit Genius, backed by Y Combinator, wants to help you quit smokingtechcrunch.com · Feb 2018

Frequently asked questions

What does Quit Genius do?
Pelago provides virtual-first substance use treatment for tobacco, alcohol, opioids, cannabis, and stimulants, combining digital tools, live counseling, and medication-assisted treatment for employers and organizations.
Who are Quit Genius's investors?
Quit Genius's investors include AAF Management Ltd., Burda Principal Investments, Atomico, Octopus Ventures, Y Combinator.